Multidrug Resistence Prevalence in COVID Area
| Autor: | Pasquale Sansone, Francesco Coppolino, Antonella Paladini, Maria Caterina Pace, Vincenzo Pota, Manlio Barbarisi, Caterina Aurilio |
|---|---|
| Přispěvatelé: | Aurilio, Caterina, Sansone, Pasquale, Paladini, Antonella, Barbarisi, Manlio, Coppolino, Francesco, Pota, Vincenzo, Pace, Maria Caterina |
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
0301 basic medicine
medicine.medical_specialty medicine.drug_class viruses Science 030106 microbiology Antibiotics multidrug-resistant medicine.disease_cause General Biochemistry Genetics and Molecular Biology 03 medical and health sciences 0302 clinical medicine Antibiotic resistance Intensive care Pandemic Medicine risk factors 030212 general & internal medicine Intensive care medicine clinical characteristics Ecology Evolution Behavior and Systematics Coronavirus business.industry clinical characteristic Paleontology Outbreak COVID-19 Multiple drug resistance Space and Planetary Science Perspective Clinical characteristics Multidrug-resistant Risk factors Viral disease business |
| Zdroj: | Life, Vol 11, Iss 601, p 601 (2021) Life |
| ISSN: | 2075-1729 |
| Popis: | Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, is often complicated by severe acute respiratory syndrome. The new coronavirus outbreak started in China in December 2019 and rapidly spread around the world. The high diffusibility of the virus was the reason for the outbreak of the pandemic viral disease, reaching more than 100 million infected people globally by the first three months of 2021. In the various treatments used up to now, the use of antimicrobial drugs for the management, especially of bacterial co-infections, is very frequent in patients admitted to intensive care. In addition, critically ill patients with SARS-CoV-2 infection are subjected to prolonged mechanical ventilation and other therapeutic procedures often responsible for developing hospital co-infections due to multidrug-resistant bacteria. Co-infections contribute to the increase in the morbidity–mortality of viral respiratory infections. We performed this study to review the recent articles published on the antibiotic bacterial resistance and viruses to predict risk factors of coronavirus disease 2019 and to assess the multidrug resistance in patients hospitalized in the COVID-19 area. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|